MENU
RCKT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Rocket Pharmaceuticals (RCKT) Ownership - Who owns Rocket Pharmaceuticals?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
9 Cedarbrook Drive
Phone
+1 609 659-8001
Employees
268
Web
https://www.rocketpharma.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.27B
P/E Ratio
N/A
Total Cash
235.66M
Projected Growth
N/A
Total Debt
25.64M
Revenue
N/A
Risk (Beta)
0.74
Dividend Yield
N/A
Total Cash/Share
2.22
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
RCKT
Capitalization
1.27B
P/E Ratio
N/A
Risk (Beta)
0.74
Dividend Yield
N/A
Total Cash
236M
Total Cash/Share
2.22
Total Debt
25.6M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
330M
P/B Ratio
3.84
Cash Flow
N/A
Earnings
-2.73
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
911K
Current Ratio
6.05
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-247.25M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-52.01
Shares Held By Institutions
2.79B
Shares Outstanding - Current
106M
Total Liabilities
63.9M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-60.227
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a provider of gene therapy services
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
9 Cedarbrook Drive
Phone
+1 609 659-8001
Employees
268
Web
https://www.rocketpharma.com